Laboratório de Lípides (LIM-10), Hospital das Clínicas (HCFMUSP) da Faculdade de Medicina da Universidade de São Paulo, São Paulo 01246-000, Brazil.
Programa de Pos-Graduação em Medicina, Universidade Nove de Julho, São Paulo 01525-000, Brazil.
Cells. 2021 Dec 29;11(1):104. doi: 10.3390/cells11010104.
In recent decades, complex and exquisite pathways involved in the endoplasmic reticulum (ER) and inflammatory stress responses have been demonstrated to participate in the development and progression of numerous diseases, among them diabetes mellitus (DM). In those pathways, several players participate in both, reflecting a complicated interplay between ER and inflammatory stress. In DM, ER and inflammatory stress are involved in both the pathogenesis of the loss of glycemic control and the development of degenerative complications. Furthermore, hyperglycemia increases the generation of advanced glycation end products (AGEs), which in turn refeed ER and inflammatory stress, contributing to worsening glycemic homeostasis and to accelerating the development of DM complications. In this review, we present the current knowledge regarding AGEs-induced and ER/inflammation-mediated regulation of the expression of GLUT4 (solute carrier family 2, facilitated glucose transporter member 4), as a marker of glycemic homeostasis and of cardiovascular disease (CVD) development/progression, as a leading cause of morbidity and mortality in DM.
近几十年来,已证实内质网 (ER) 和炎症应激反应中涉及的复杂而精细的途径参与了许多疾病的发生和发展,其中包括糖尿病 (DM)。在这些途径中,有几个参与者同时参与其中,反映了 ER 和炎症应激之间复杂的相互作用。在 DM 中,ER 和炎症应激均参与血糖控制丧失的发病机制和退行性并发症的发展。此外,高血糖会增加晚期糖基化终产物 (AGEs) 的产生,这反过来又会重新激活 ER 和炎症应激,导致血糖稳态恶化,并加速 DM 并发症的发展。在这篇综述中,我们介绍了目前关于 AGEs 诱导的和 ER/炎症介导的 GLUT4(溶质载体家族 2,易化葡萄糖转运蛋白成员 4)表达调控的知识,GLUT4 是血糖稳态和心血管疾病 (CVD) 发展/进展的标志物,也是 DM 发病率和死亡率的主要原因。